Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy.

Area of Science:

• Oncology
• Biotechnology
• Nanomedicine

Background:

• Cancer is a leading global cause of death, with increasing incidence and challenges from tumor heterogeneity and multidrug resistance.
• Gene therapy presents a potential therapeutic strategy by modifying the genetic code to inhibit tumor progression, angiogenesis, and metastasis.
• Effective gene delivery to tumor cells requires specialized vectors to protect and transport therapeutic genes.

Purpose of the Study:

• To review and discuss targeting ligands used for functionalizing liposomes.
• To explore the potential of ligand-functionalized liposomes in improving gene delivery for cancer treatment.

Main Methods:

• Review of scientific literature on gene therapy, liposomes, and targeting ligands for cancer treatment.
• Analysis of different types of targeting ligands (antibodies, peptides, aptamers, folic acid, carbohydrates) used in liposome functionalization.
• Discussion of the role of receptor-ligand interactions in selective tumor targeting.

Main Results:

• Liposomes are effective nonviral vectors for gene delivery due to low immunogenicity and toxicity.
• Surface modification of liposomes with specific ligands enhances selective gene delivery to tumor cells overexpressing target receptors.
• Targeting ligands facilitate high-affinity binding to tumor cells, improving the efficiency of gene therapy.

Conclusions:

• Ligand-functionalized liposomes represent a significant advancement in targeted gene delivery for cancer therapy.
• Optimizing ligand selection and liposome design can further enhance the efficacy and specificity of gene-based cancer treatments.
• This approach holds considerable promise for developing novel and more effective cancer treatment strategies.